Long-term clinical outcome of fetal cell transplantation for parkinson disease: Two case reports

JAMA Neurology

Volumn 71, Issue 1, 2014, Pages 83-87

  Kefalopoulou, Zinovia ^a   Politis, Marios ^b   Piccini, Paola ^b   Mencacci, Niccolo ^c   Bhatia, Kailash ^a   Jahanshahi, Marjan ^a   Widner, Håkan ^d   Rehncrona, Stig ^d   Brundin, Patrik ^e   Björklund, Anders ^e   Lindvall, Olle ^d   Limousin, Patricia ^a   Quinn, Niall ^a   Foltynie, Thomas ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

CASE REPORT; CORPUS STRIATUM; CYTOLOGY; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; FETAL TISSUE TRANSPLANTATION; FOLLOW UP; HUMAN; MALE; MESENCEPHALON; MIDDLE AGED; PARKINSON DISEASE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; SURGERY; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

CORPUS STRIATUM; DOPAMINERGIC NEURONS; FETAL TISSUE TRANSPLANTATION; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MESENCEPHALON; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892394291     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.4749     Document Type: Article

References (21)

1. Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders: time for clinical translation? J Clin Invest. 2010; 120(1):29-40.
2. Barker RA, Barrett J, Mason S.L., Björklund A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. Lancet Neurol. 2013; 12(1):84-91.
3. Hagell P, Schrag A, Piccini P., et al Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain. 1999; 122(pt 6):1121-1132.
4. Brundin P, Pogarell O, Hagell P., et al Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain. 2000; 123(pt 7):1380-1390.
5. Langston JW, Widner H, Goetz C.G., et al Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992; 7(1):2-13.
6. Politis M, Wu K, Loane C., et al Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med. 2010; 2(38):38ra46.
7. Hagell P, Piccini P, Björklund A, et al Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci. 2002; 5(7):627-628.
8. Evans JR, Mason SL, Williams-Gray CH, et al The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry. 2011; 82(10):1112-1118.
9. Hely MA, Reid WG, Adena M.A., Halliday GM, Morris JG The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008; 23(6):837-844.
10. Piccini P, Pavese N, Hagell P., et al Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain. 2005; 128(pt 12):2977-2986.
11. Freed CR, Greene PE, Breeze R.E., et al Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001; 344(10):710-719.
12. Olanow CW, Goetz CG, Kordower J.H., et al A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003; 54(3):403-414.
13. Lindvall O, Björklund A. Cell therapy in Parkinson's disease. NeuroRx. 2004; 1(4):382-393.
14. Piccini P, Brooks DJ, Björklund A, et al Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci. 1999; 2(12):1137-1140.
15. Politis M, Oertel WH, Wu K, et al Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio. Mov Disord. 2011; 26(11):1997-2003.
16. Graff-Radford J., Foote KD, Rodriguez R.L., et al Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch Neurol. 2006; 63(8):1181-1184.
17. Herzog J, Pogarell O, Pinsker M.O., et al Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Mov Disord. 2008; 23(9):1293-1296.
18. Li JY, Englund E, Holton J.L., et al Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med. 2008; 14(5):501-503.
19. Kordower JH, Chu Y, Hauser R.A., Freeman TB, Olanow CW Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med. 2008; 14(5):504-506.
20. Brundin P, Kordower JH Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy. Prog Brain Res. 2012; 200:221-241.
21. Politis M, Wu K, Loane C., et al Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts. Sci Transl Med. 2012; 4(128):28ra41.